Back to Search
Start Over
Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study.
- Source :
-
JCO Precision Oncology . Feb2022, p1-5. 5p. - Publication Year :
- 2022
-
Abstract
- Two targets with one arrow: #Immunotherapy as single treatment for synchronous RRD #glioblastoma and #metastatic cancers. [ABSTRACT FROM AUTHOR]
- Subjects :
- *IMMUNE checkpoint inhibitors
*CANCER treatment
Subjects
Details
- Language :
- English
- ISSN :
- 24734284
- Database :
- Academic Search Index
- Journal :
- JCO Precision Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 157489797
- Full Text :
- https://doi.org/10.1200/PO.21.00286